Scientific Integrity
Sustainability
Accessibility
Innovation
About Us
MD NutriAcademy is a deep-tech company dedicated to transforming the future of personalized nutrition and health through the integration of multi-omics, systems biology, and AI-powered bioinformatics.
Founded with the vision of making cutting-edge science accessible, MD NutriAcademy aims to empower individuals to take charge of their health, starting from the gut microbiome.
Mission
Our mission is to deliver innovative, data-driven, and sustainable health solutions that address the unique needs of every individual — with a special focus on women’s health, athletic performance, and healthy aging.
Born from a passion for science and human-centered innovation, MD NutriAcademy brings together expertise from molecular biology, genetics, nutrition, and artificial intelligence to create truly personalized insights.
At MD NutriAcademy, we believe that the future of health lies in understanding the complex biological networks within us — and unlocking their potential through the power of technology.
Empowerment through
Knowledge
About
Ilknur Melis Durası, Ph.D.
Dr. İlknur Melis Durası is a scientist, entrepreneur, and academic specializing in bioinformatics, multi-omics technologies, and systems biology.
Her research focuses on integrating molecular biology, genetics, and nutrition sciences to shape the future of personalized health solutions.
Combining insights from gut microbiome research, gene expression studies, and systems biology, Melis Durası leverages AI-driven analytics to create accessible and effective health technologies.
Driven by this vision, she founded MD NutriAcademy, a deep-tech company that integrates multi-omics data (microbiome, genomics, epigenetics) and AI-powered bioinformatics to deliver personalized nutrition and health recommendations.
MD NutriAcademy primarily focuses on women’s health, athletic performance optimization, and healthy aging.
She defines her personal mission as "human-centered innovation inspired by science."
By bridging the worlds of scientific research and entrepreneurship, she aims to empower individuals to take charge of their health through a more holistic, data-driven, and conscious approach.
Founder & CEO
Ph.D. Molecular Biology, Genetics & Bioengineering
Bioinformatics & Systems Biology
BSc Molecular Biology, Genetics & Bioengineering
BSc Nutrition and Dietetics
TEDX Speaker
Professional Athlete - former
PUBLICATIONS & CONFERENCES
• Speaker, “Microbiome and Personalized Diet”, at International Cost Charme Summer School 2019.
• Speaker, “Beslenme Araştırmalarında Sistem Biyolojisi Uygulamaları”, at 8.Ulusal Sağlıklı Yaşam Kongresi, 2019.
• Book Chapter: “Bioinformatics Workflows for Genomic Variant Discovery, Interpretation and Prioritization”. In book: Bioinformatics Tools for Detection and Clinical Interpretation of Genomic Variations. June 2019.
• EMBL-EMBO Human Microbiome Symposium, Oral & Poster Presentation, “Revealing the miRNA regulatory pathways in colorectal cancer by prioritizing disease-related miRNAs correlated with gut microbiata”.
• 3rd European Summer School on Nutrigenomics, Selected Presentation, “Analysis of Expression Data Using Directed Signalling Network Identifies Regulatory Pathways in Human Obesity”, June 25-29, 2018, Italy.
• 11th Congress of the International Society of Nutrigenetics/Nutrigenomics, September 16-19, 2017, LosAngeles,CA,USA (participant).
• 6. Ulusal Sağlıklı Yaşam Sempozyumu ve 1. Yaşam İçin Beslenme ve Spor Kongresi, “Besin Seçim Anketinin Türkiye’de 12-21 Yaş Grubunda Uygulanması”, Accepted Oral Presentation, Best Project & Best Oral Presentation Reward, 2017.
• Plos One,(Research Article), “In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons”, 2016.
• Nature Communications, "IDH-mutant Glioma specific association of rs55705857 located at 8q24.21 involves Myc deregulation", 2016.
• Neuroscience Letters, “Potential of GRID2 receptor gene for preventing TNF-induced neurodegeneration in autism”, May 4, 2016.
• Toxicology and Applied Pharmacology, “Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure”. December 1,2015.
• Plos One,(Research Article), “CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes”, May 5,2015.
• 67th American Academy of Neurology (AAN) Annual Meeting in Washington, DC, “Proteomic Analysis in CSF Identified Subtype Specific and Shared Molecular Pathways for Multiple Sclerosis Clinical Phenotypes”, April 1825, 2015.
• International Conference on Applied Informatics for Health and Life Sciences in conjunction with Turkish-German Workshop on Bioinformatics: Recent Developments from Health to Nanotechnology, Tutorial Given as a Speaker:“Introduction to DAVID and PANOGA Bioinformatics Resources”, 2014.
• International Conference on Applied Informatics for Health and Life Sciences Turkish-German Workshop on Bioinformatics: Recent Developments from Health to Nanotechnology, “Identification of Pathways from Proteomic Analysis with DAVID and PANOGA”, Kuşadası-TÜRKİYE, 19-22 October 2014.
• 62nd American Society Human Genetics Annual Meeting in San Francisco, “Disease Specific Pathway Analysis in Multiple Sclerosis”, November, 2012.
• International Symposium on Health Informatics and Bioinformatics, “Identification of Transcription Factor Binding Sites in Promoter Databases”, 2011.